
Clene Inc. — Investor Relations & Filings
Clene Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing nanotherapeutics to treat neurodegenerative diseases. The company's approach centers on its proprietary technology platform, which creates clean-surfaced, catalytically-active nanocrystals. These nanotherapeutics are designed to address cellular energy impairments, a key factor in the progression of many neurological conditions. By targeting these bioenergetic deficits, Clene aims to restore and protect neuronal health and function. The company is advancing a pipeline of drug candidates to address high unmet medical needs in diseases such as amyotrophic lateral sclerosis (ALS) and multiple sclerosis.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| FORM SD | 2026-05-22 | English | |
| FORM 8-K | 2026-05-22 | English | |
| FORM 8-K | 2026-05-14 | English | |
| FORM 10-Q | 2026-05-14 | English | |
| 424B5 - Clene Inc. (0001822791) (Filer) | 2026-05-05 | English | |
| 424B5 - Clene Inc. (0001822791) (Filer) | 2026-05-05 | English |
Browse filings by year
7 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 46860589 | FORM SD | 2026-05-22 | English | ||
| 46860002 | FORM 8-K | 2026-05-22 | English | ||
| 45994087 | FORM 8-K | 2026-05-14 | English | ||
| 45988453 | FORM 10-Q | 2026-05-14 | English | ||
| 41552311 | 424B5 - Clene Inc. (0001822791) (Filer) | 2026-05-05 | English | ||
| 41541458 | 424B5 - Clene Inc. (0001822791) (Filer) | 2026-05-05 | English | ||
| 40890003 | 8-K - Clene Inc. (0001822791) (Filer) | 2026-05-04 | English | ||
| 32963513 | 10-K - Clene Inc. (0001822791) (Filer) | 2026-03-17 | English | ||
| 32899074 | 8-K - CLENE INC. (0001822791) (Filer) | 2026-02-24 | English | ||
| 32899066 | 4 - CLENE INC. (0001822791) (Filer) | 2026-02-20 | English | ||
| 32899067 | 4 - CLENE INC. (0001822791) (Filer) | 2026-02-20 | English | ||
| 32899068 | 4 - CLENE INC. (0001822791) (Filer) | 2026-02-20 | English | ||
| 32899069 | 4 - CLENE INC. (0001822791) (Filer) | 2026-02-20 | English | ||
| 32899072 | 4 - CLENE INC. (0001822791) (Filer) | 2026-02-20 | English | ||
| 32899070 | 4 - CLENE INC. (0001822791) (Filer) | 2026-02-20 | English | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
ANTEROGEN CO., LTD.
Develops and commercializes cell therapies and orphan drugs…
|
065660 | KR | Manufacturing |
|
Antibiotice S.A.
Pharmaceutical firm manufacturing generic medicines, anti-i…
|
ATB | RO | Manufacturing |
|
Anuh Pharma Ltd.
Manufacturer of APIs and bulk drugs specializing in Macroli…
|
ANUHPHR | IN | Manufacturing |
|
Apellis Pharmaceuticals, Inc.
Biopharmaceutical company developing therapies by targeting…
|
APLS | US | Manufacturing |
|
Apeloa Pharmaceutical Co.,Ltd.
Integrated provider of APIs, CDMO services, and finished dr…
|
000739 | CN | Manufacturing |
|
APEX HEALTHCARE BERHAD
Integrated pharmaceutical group manufacturing and distribut…
|
— | MY | Manufacturing |
|
ApicHope Pharmaceutical Group Co.,Ltd
Pharmaceutical firm focused on pediatric, chronic, and card…
|
300723 | CN | Manufacturing |
|
Apimeds Pharmaceuticals US, Inc.
Clinical-stage biopharma developing a bee venom drug and AI…
|
APUS | US | Manufacturing |
|
Apogee Therapeutics, Inc.
Clinical-stage biotech developing biologics for immunologic…
|
APGE | US | Manufacturing |
|
Apollomics Inc.
Clinical-stage biotech developing innovative oncology and c…
|
APLM | US | Manufacturing |
Clene Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34487/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34487 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34487 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34487 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34487}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Clene Inc. (id: 34487)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.